SolaranRx
Company

SolaranRx

Biotechnology Research Albuquerque, New Mexico, United States 12 employees
Employees
12
Contacts
2
Emails
2
Phones
1

SolaranRx Overview

Headquarters
Albuquerque, New Mexico, United States
Industry
Biotechnology Research
Employees
12
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About SolaranRx

SolaranRx is focused on developing a new class of therapies and companion imaging agents to treat metastatic melanoma. It has developed a Precision Theranostic Platform™ that targets metastatic melanoma tumors with a radiolabeled peptide. It claims that the technology has a therapeutic potential with minimum side effects. SolaranRx is focused on developing its lead product SRX-1177, a novel peptide linked to a radioisotope that preferentially attaches to melanocortin-1 (MC1) receptors. The candidate has been granted Orphan Drug designation by the FDA based on compelling pre-clinical evidence.

SolaranRx Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

SolaranRx Org Chart

Sample employees and titles
Name Title Contact
Shelly Kujawa VP / Therapeutic Riding Instructor
View
Nancy Ficili Pet Stylist Petsmart
Email
Autumn Zick Therapeutic Equestrian Center Board
Email Phone
Laurie Bishop Volunteer at Therapeutic Equestrian
View

Employees by Management Level

Individual contributor 3 profiles
VP / Head 1 profile

Compare Similar Companies to SolaranRx